beta-catenin inhibitor (MD2 Biosciences)

N/A

Report date: 2025/01/26 19:17:25

NME

Base Information

Drug Namebeta-catenin inhibitor (MD2 Biosciences)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCatenin beta 1 degraders

TargetsCatenin beta 1

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMD2 Biosciences Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsColorectal Neoplasms

Inactive IndicationsN/A

ATC CodeN/A